FDA grants BTD for Venclexta in combination with azacitidine to treat patients with myelodysplastic syndromes Read more
US FDA nod for Roche’s VENTANA ALK (D5F3) CDx assay as companion diagnostic for NSCLC treatment with LORBRENA Read more
Drug makers, BMGF pledge to strive for global access to COVID-19 diagnostics, therapeutics and vaccines Read more